EMIF: E-managing the Future of Health Data

Click on the names to download specific presentations or scroll to the bottom to get the whole pack.

Introduction

• Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF

Discovery: Real World Evidence as a Tool for Translation

• Johan Liwing, Director Market Access RWE Partnerships, Global Commercial Strategy Organization, Janssen-Cilag AG
• John Gallacher, Professor, University of Oxford, Medical Sciences Division, Director, MRC Dementias Platform UK
• Ferran Sanz, Director, GRIB
• Tõnu Esko, Deputy Director of Research at Estonian Genome Center, University of Tartu

Development: Optimising Execution, Feasibility and Efficacy

• Dipak Kalra, President, EuroRec; EHR4CR
• Iain Buchan, Clinical Professor in Public Health Informatics, Centre for Health Informatics, University of Manchester
• Alison Bourke, Scientific Director, Real World Evidence, IMS Health

Deployment: Market Access, Pharmacovigilance, and Effectiveness

• Rients van Wijngaarden, Senior Data Scientist, PHARMO Institute
• Johan Van Bussel, Head of the department healthdata.be, Belgian Scientific Institute Public Health
• Sarah Garner, Associate Director Science Policy and Research, National Institute for Health and Clinical Excellence (NICE)
• Andrew Roddam, Vice President & Global Head Epidemiology at GSK

The Opportunities for Real World Data for research

• Richard Bergstrom, Director General, EFPIA
• Ann Martin, Principal Scientific Manager, IMI – replaced by Bart Vannieuwenhuyse, Senior Director Health Information Sciences, Janssen Pharmaceutica; Coordinator EMIF
• Balázs Fürjes, Director, EIT Health InnoStars
• Miklós Bacskai, Chief Strategy & Business Development Officer, Healthware

DOWNLOAD ALL PRESENTATIONS HERE